Hap Trading, LLC I Bio, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $3,197 - $2.22 Million	-13,900 Reduced 33.49%	27,600 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $10,557 - $21,114	-45,900 Reduced 52.52%	41,500 $1,000
Q1 2022 May 12, 2022	SELL	$0.3 - $0.61 $2,970 - $6,039	-9,900 Reduced 10.17%	87,400 $6,000
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $3,410 - $6,448	-6,200 Reduced 5.99%	97,300 $2,000
Q3 2021 Nov 10, 2021	BUY	$1.06 - $1.52 $26,288 - $37,696	24,800 Added 31.51%	103,500 $7,000
Q2 2021 Aug 11, 2021	BUY	$1.22 - $1.65 $488 - $660	400 Added 0.51%	78,700 $27,000
Q1 2021 May 14, 2021	BUY	$1.18 - $2.62 $9,676 - $21,484	8,200 Added 11.7%	78,300 $35,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $73,605 - $157,024	70,100 New	70,100 $14,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.